Therefore, NMT1/NMT2 catalysis during productive HIV infection in its principal target cells (i.e., CD4 T cells) should be explored to better understand its role in HIV infection and then as a potential therapeutic target. The gene discussed is CD4; the disease is HIV infectious disease.